133 related articles for article (PubMed ID: 9722300)
1. Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: differences in outcome are poorly explained by the most significant prognostic variables. Fralle group. French Acute Lymphoblastic Leukaemia study group.
Donadieu J; Auclerc MF; Baruchel A; Leblanc T; Landman-Parker J; Perel Y; Michel G; Cornu G; Bordigoni P; Sommelet D; Leverger G; Hill C; Schaison G
Br J Haematol; 1998 Aug; 102(3):729-39. PubMed ID: 9722300
[TBL] [Abstract][Full Text] [Related]
2. Prognostic study of continuous variables (white blood cell count, peripheral blast cell count, haemoglobin level, platelet count and age) in childhood acute lymphoblastic leukaemia. Analysis Of a population of 1545 children treated by the French Acute Lymphoblastic Leukaemia Group (FRALLE).
Donadieu J; Auclerc MF; Baruchel A; Perel Y; Bordigoni P; Landman-Parker J; Leblanc T; Cornu G; Sommelet D; Leverger G; Schaison G; Hill C;
Br J Cancer; 2000 Dec; 83(12):1617-22. PubMed ID: 11104555
[TBL] [Abstract][Full Text] [Related]
3. Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials.
Boissel N; Auclerc MF; Lhéritier V; Perel Y; Thomas X; Leblanc T; Rousselot P; Cayuela JM; Gabert J; Fegueux N; Piguet C; Huguet-Rigal F; Berthou C; Boiron JM; Pautas C; Michel G; Fière D; Leverger G; Dombret H; Baruchel A
J Clin Oncol; 2003 Mar; 21(5):774-80. PubMed ID: 12610173
[TBL] [Abstract][Full Text] [Related]
4. Cytogenetics and prognosis in childhood lymphoblastic leukaemia: results of MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia.
Chessels JM; Swansbury GJ; Reeves B; Bailey CC; Richards SM
Br J Haematol; 1997 Oct; 99(1):93-100. PubMed ID: 9359508
[TBL] [Abstract][Full Text] [Related]
5. Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol.
Hann I; Vora A; Harrison G; Harrison C; Eden O; Hill F; Gibson B; Richards S;
Br J Haematol; 2001 Apr; 113(1):103-14. PubMed ID: 11328289
[TBL] [Abstract][Full Text] [Related]
6. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of therapy results and prognostic factors in children with acute lymphoblastic leukaemia in Warmia and Mazury region: 17-years experience].
Badowska W
Med Wieku Rozwoj; 2008; 12(4 Pt 2):1001-7. PubMed ID: 19531816
[TBL] [Abstract][Full Text] [Related]
9. Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial.
Moorman AV; Ensor HM; Richards SM; Chilton L; Schwab C; Kinsey SE; Vora A; Mitchell CD; Harrison CJ
Lancet Oncol; 2010 May; 11(5):429-38. PubMed ID: 20409752
[TBL] [Abstract][Full Text] [Related]
10. [Prognosis of acute lymphoblastic leukemia in children. Results of the French protocol FRALLE 93].
Schaison G; Auclerc MF; Baruchel A; Leblanc T; Leverger G
Bull Acad Natl Med; 2001; 185(1):149-60; discussion 160-2. PubMed ID: 11474564
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: the FRALLE 93 study.
Oudot C; Auclerc MF; Levy V; Porcher R; Piguet C; Perel Y; Gandemer V; Debre M; Vermylen C; Pautard B; Berger C; Schmitt C; Leblanc T; Cayuela JM; Socie G; Michel G; Leverger G; Baruchel A
J Clin Oncol; 2008 Mar; 26(9):1496-503. PubMed ID: 18349402
[TBL] [Abstract][Full Text] [Related]
12. Defining low-risk high hyperdiploidy in patients with paediatric acute lymphoblastic leukaemia: a retrospective analysis of data from the UKALL97/99 and UKALL2003 clinical trials.
Enshaei A; Vora A; Harrison CJ; Moppett J; Moorman AV
Lancet Haematol; 2021 Nov; 8(11):e828-e839. PubMed ID: 34715050
[TBL] [Abstract][Full Text] [Related]
13. Age, sex, haemoglobin level, and white cell count at diagnosis are important prognostic factors in children with acute lymphoblastic leukemia treated with BFM-type protocol.
Ng SM; Lin HP; Ariffin WA; Zainab AK; Lam SK; Chan LL
J Trop Pediatr; 2000 Dec; 46(6):338-43. PubMed ID: 11191144
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.
Möricke A; Zimmermann M; Reiter A; Gadner H; Odenwald E; Harbott J; Ludwig WD; Riehm H; Schrappe M
Klin Padiatr; 2005; 217(6):310-20. PubMed ID: 16307416
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of karyotypic findings in childhood acute lymphoblastic leukaemia: a Nordic series comparing two treatment periods. For the Nordic Society of Paediatric Haematology and Oncology (NOPHO) Leukaemia Cytogenetic Study Group.
Forestier E; Johansson B; Gustafsson G; Borgström G; Kerndrup G; Johannsson J; Heim S
Br J Haematol; 2000 Jul; 110(1):147-53. PubMed ID: 10930992
[TBL] [Abstract][Full Text] [Related]
16. Treatment of infants with lymphoblastic leukaemia: results of the UK Infant Protocols 1987-1999.
Chessells JM; Harrison CJ; Watson SL; Vora AJ; Richards SM;
Br J Haematol; 2002 May; 117(2):306-14. PubMed ID: 11972512
[TBL] [Abstract][Full Text] [Related]
17. Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials.
Chessells JM; Richards SM; Bailey CC; Lilleyman JS; Eden OB
Br J Haematol; 1995 Feb; 89(2):364-72. PubMed ID: 7873387
[TBL] [Abstract][Full Text] [Related]
18. Impact of chromosomal translocations on prognosis in childhood acute lymphoblastic leukemia.
Rubin CM; Le Beau MM; Mick R; Bitter MA; Nachman J; Rudinsky R; Appel HJ; Morgan E; Suarez CR; Schumacher HR
J Clin Oncol; 1991 Dec; 9(12):2183-92. PubMed ID: 1960559
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).
Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G
Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914
[TBL] [Abstract][Full Text] [Related]
20. Validation of the 'French Acute Lymphoblastic Leukaemia Study Group FRALLE prognostic index' for paediatric Philadelphia-chromosome acute lymphoblastic leukaemia.
Rives S; Camós M; Estella J; Gómez P; López-Duarte M; Navajas A; Badell I
Br J Haematol; 2012 Jan; 156(2):284-6. PubMed ID: 21923654
[No Abstract] [Full Text] [Related]
[Next] [New Search]
